Published in Heart on May 01, 1996
Utility of corrected QT interval in orthostatic intolerance. PLoS One (2014) 1.39
Electrocardiographic repolarization abnormalities in familial dysautonomia: an indicator of cardiac autonomic dysfunction. Clin Auton Res (1999) 0.83
Prolonged Corrected QT Interval in Patients with Myotonic Dystrophy Type 1. J Clin Neurol (2013) 0.80
Can abnormalities of ventricular repolarisation identify insulin dependent diabetic patients at risk of sudden cardiac death? Heart (1997) 0.75
Comparison of QT interval duration and dispersion in elderly population versus healthy young subjects. Clin Auton Res (2004) 0.75
QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J (1990) 4.28
The long Q-T syndrome. Am Heart J (1975) 3.75
The natural history of diabetic autonomic neuropathy. Q J Med (1980) 3.36
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation (1978) 3.32
Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report. Circulation (1991) 2.87
Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation (1983) 2.74
Natural history of autonomic neuropathy in chronic liver disease. Lancet (1992) 2.03
Relationship between electrocardiogram and electrolytes. Am Heart J (1967) 1.53
Influence of the autonomic nervous system on the Q-T interval in man. Am J Cardiol (1982) 1.45
Prolonged QT-interval syndromes. JAMA (1986) 1.31
Influence of heart rate and inhibition of autonomic tone on the QT interval. Circulation (1982) 1.30
QT interval length and diabetic autonomic neuropathy. Diabet Med (1990) 1.18
Diurnal variation of the QT interval--influence of the autonomic nervous system. Br Heart J (1986) 1.13
Autonomic neuropathy and chronic liver disease. Q J Med (1989) 1.13
Sympathetic and vagal influences on rate-dependent changes of QT interval in healthy subjects. Am J Cardiol (1991) 1.06
Autonomic neuropathy and prolongation of QT-interval in liver disease. Lancet (1992) 1.05
Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death? Br Heart J (1988) 1.05
Relationship between the degree of coronary artery disease and of left ventricular function and the duration of the QT-interval in ECG. Eur Heart J (1986) 0.96
Delayed repolarization (QT or QTU prolongation) and malignant ventricular arrhythmias. Mod Concepts Cardiovasc Dis (1982) 0.94
Survival of patients with multiple system atrophy. Intern Med (1994) 0.92
Information on type 1 diabetes mellitus and QT interval from identical twins. Am J Cardiol (1993) 0.89
Dispersion of ventricular repolarization in the long QT syndrome. Am J Cardiol (1991) 0.87
Role of the autonomic nervous system in sudden death. Cardiovasc Clin (1985) 0.82
Autonomic effects on the human cardiac conduction system. Evaluation by intracardiac electrocardiography and programmed stimulation techniques. Br Heart J (1980) 0.82
Choice of electrocardiographic leads for recording the earliest QRS onset in noninvasive measurements. Circulation (1981) 0.78
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Neural activity relating to generation and representation of galvanic skin conductance responses: a functional magnetic resonance imaging study. J Neurosci (2000) 3.49
Neural activity in the human brain relating to uncertainty and arousal during anticipation. Neuron (2001) 3.49
Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med (1997) 3.13
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol (1995) 2.76
Cerebral correlates of autonomic cardiovascular arousal: a functional neuroimaging investigation in humans. J Physiol (2000) 2.72
International standards to document remaining autonomic function after spinal cord injury. Spinal Cord (2008) 2.65
Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol (1990) 2.45
Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 2.42
Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry (1998) 2.19
Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology (2000) 2.19
A gallium-68 radiopharmaceutical that is retained in myocardium: 68Ga[(4,6-MeO2sal)2BAPEN]+. J Nucl Med (1993) 2.06
Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry (2001) 1.68
Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine. Lancet (1997) 1.65
Performance of a 62Zn/62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM. J Nucl Med (2000) 1.65
Neuroanatomical basis for first- and second-order representations of bodily states. Nat Neurosci (2001) 1.61
The prevalence and association of neck (coat-hanger) pain and orthostatic (postural) hypotension in human spinal cord injury. Spinal Cord (2002) 1.55
Breast cancer: PET imaging of estrogen receptors. Radiology (1988) 1.53
Physiological assessment of aspects of autonomic function in patients with secondary progressive multiple sclerosis. J Neurol (1993) 1.52
Organisation of the sympathetic skin response in spinal cord injury. J Neurol Neurosurg Psychiatry (2002) 1.49
Reduced nitrogen in ecology and the environment. Environ Pollut (2007) 1.49
Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (the Framingham Heart Study). Am J Cardiol (1992) 1.46
New autonomic and sensory neuropathy with loss of adrenergic sympathetic function and sensory neuropeptides. Lancet (1991) 1.43
Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol (1983) 1.42
Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators. J Am Coll Cardiol (2000) 1.40
Cardiovascular, autonomic, and plasma catecholamine responses in unilateral and bilateral carotid artery stenosis. J Neurol Neurosurg Psychiatry (1999) 1.40
Detailed examination of fenfluramine-phentermine users with valve abnormalities identified in Fargo, North Dakota. Am J Cardiol (1999) 1.39
Clinical Autonomic Research in the 1990s. Clin Auton Res (1991) 1.39
EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol (2006) 1.37
Unexplained syncope--is screening for carotid sinus hypersensitivity indicated in all patients aged >40 years? J Neurol Neurosurg Psychiatry (2006) 1.30
Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology (2002) 1.26
Plasma catecholamines, plasma renin activity and plasma aldosterone in tetraplegic man, horizontal and tilted. Clin Sci Mol Med (1975) 1.26
Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology (2009) 1.26
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol (1992) 1.23
Autonomic disorders and their recognition. N Engl J Med (1997) 1.22
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology (2003) 1.22
Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma. J Nucl Med (1991) 1.21
Mechanisms of reflex cardiac arrest in tetraplegic patients. Lancet (1975) 1.21
Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets. Lancet (1978) 1.17
Antianginal effects of nitroglycerin patches. Am J Cardiol (1984) 1.16
Intravenous morphine causes hypertension, hyperglycaemia and increases sympatho-adrenal outflow in conscious rabbits. Clin Sci (Lond) (1988) 1.16
Autonomic failure preceding dementia with Lewy bodies. J Neurol (2000) 1.15
A novel TRK A (NTRK1) mutation associated with hereditary sensory and autonomic neuropathy type V. Ann Neurol (2001) 1.14
Brain activity during biofeedback relaxation: a functional neuroimaging investigation. Brain (2001) 1.13
Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results. Circulation (1983) 1.12
The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed) (1986) 1.11
Dissecting aneurysm of the pulmonary trunk in mitral stenosis. Am J Cardiol (1986) 1.09
Double-blind, parallel, comparative multicentre study of a new combination of diltiazem and hydrochlorothiazide with individual components in patients with mild or moderate hypertension. J Hum Hypertens (1996) 1.08
Plasma and urinary dopamine: studies during fasting and exercise and in tetraplegic man. Eur J Clin Invest (1976) 1.07
Plasma catecholamines during paroxysmal neurogenic hypertension in quadriplegic man. Circ Res (1976) 1.06
The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05
Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging. Bioconjug Chem (1996) 1.05
Abnormality of superior mesenteric artery blood flow responses in human sympathetic failure. J Physiol (1992) 1.04
Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution. Br J Pharmacol (1989) 1.03
Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical. Bioconjug Chem (1997) 1.03
Enhanced pressor response to noradrenaline in patients with cervical spinal cord transection. Brain (1976) 1.02
Ultrafast three-dimensional contrast-enhanced magnetic resonance angiography and imaging in the diagnosis of partial anomalous pulmonary venous drainage. J Am Coll Cardiol (2001) 1.02
Postural hypotension enhanced by exercise in patients with chronic autonomic failure. QJM (1995) 1.01
Fluorine-18 labeling of proteins. J Nucl Med (1987) 1.00
Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion. J Nucl Med (1990) 0.99
Action of 5 Hz repetitive transcranial magnetic stimulation on sensory, motor and autonomic function in human spinal cord injury. Clin Neurophysiol (2011) 0.99
Severe hypertension in patients with high spinal cord lesions undergoing electro-ejaculation--management with prostaglandin E2. Paraplegia (1980) 0.98
International spinal cord injury cardiovascular function basic data set. Spinal Cord (2010) 0.98
Abnormal regional blood flow responses during and after exercise in human sympathetic denervation. J Physiol (1997) 0.98
Development of quantitative and sensitive assessments of physiological and functional outcome during recovery from spinal cord injury: a clinical initiative. Brain Res Bull (2010) 0.97
Pressor effect of arginine vasopressin in progressive autonomic failure. Clin Sci (Lond) (1986) 0.97
Chronic cough in the Holmes-Adie syndrome: association in five cases with autonomic dysfunction. J Neurol Neurosurg Psychiatry (1998) 0.96
Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study. Int J Impot Res (2003) 0.96
Increased sensitivity of the denervated transplanted human heart to isoprenaline both before and after beta-adrenergic blockade. Circulation (1987) 0.96
Amrinone in the treatment of chronic cardiac failure. J Am Coll Cardiol (1984) 0.95
The haemodynamic and hormonal responses after clonidine occur independently of sedation in essential hypertension. Br J Clin Pharmacol (1989) 0.95
Characterization of the uptake of 16 alpha-([18F]fluoro)-17 beta-estradiol in DMBA-induced mammary tumors. Int J Rad Appl Instrum B (1987) 0.94
Evaluation of antioxidant activity of Brazilian plants. Pharmacol Res (2005) 0.94
Indium-III: a new radionuclide label for studying human platelet kinetics. Br J Haematol (1979) 0.94
Slow recovery from severe foodborne botulism. Lancet (1989) 0.94
Social and motivational functioning is not critically dependent on feedback of autonomic responses: neuropsychological evidence from patients with pure autonomic failure. Neuropsychologia (2004) 0.94
Continuous haemodynamic monitoring in an unusual case of swallow induced syncope. J Neurol Neurosurg Psychiatry (1999) 0.93
Abnormal cardiovascular and catecholamine responses to supine exercise in human subjects with sympathetic dysfunction. J Physiol (1995) 0.92
Structure-distribution relationships for metal-labeled myocardial imaging agents: comparison of a series of cationic gallium (III) complexes with hexadentate bis(salicylaldimine) ligands. J Med Chem (1994) 0.92
The central hypotensive effect of clonidine. Studies in tetraplegic subjects. Clin Pharmacol Ther (1977) 0.92
Evidence that intravenous morphine stimulates central opiate receptors to increase sympatho-adrenal outflow and cause hypertension in conscious rabbits. Clin Sci (Lond) (1989) 0.92
Circulatory reflexes in tetraplegics during artifical ventilation and general anaesthesia. Paraplegia (1975) 0.91
Frequency of family history in vasovagal syncope. Lancet (1998) 0.91
Doppler echocardiographic comparison of the Carpentier and Duran anuloplasty rings versus no ring after mitral valve repair for mitral regurgitation. Am J Cardiol (1991) 0.91
Syncope associated with pain as the presenting feature of neck malignancy: failure of cardiac pacemaker to prevent attacks in two cases. J Neurol Neurosurg Psychiatry (2005) 0.91
beta-Receptor numbers and thermodynamics in denervation supersensitivity. J Physiol (1981) 0.91
Renin release during head-up tilt occurs independently of sympathetic nervous activity in tetraplegic man. Clin Sci (Lond) (1980) 0.91
Effect of dobutamine on regional left ventricular function measured by tagged magnetic resonance imaging in normal subjects. Am J Cardiol (1999) 0.90
Progression of cardiovascular autonomic dysfunction in Holmes-Adie syndrome. J Neurol Neurosurg Psychiatry (2010) 0.90
Effect of meal size on post-prandial blood pressure and on postural hypotension in primary autonomic failure. Clin Auton Res (1996) 0.90
Haemodynamics of the pressor effect of oral water in human sympathetic denervation due to autonomic failure. Clin Sci (Lond) (2001) 0.90
Relationship between splanchnic vasodilation and postprandial hypotension in patients with primary autonomic failure. J Hypertens Suppl (1989) 0.89
Information on type 1 diabetes mellitus and QT interval from identical twins. Am J Cardiol (1993) 0.89
Cardiovascular aspects of autonomic dysreflexia since Guttmann and Whitteridge (1947). Paraplegia (1979) 0.89
Cardiovascular control in recently injured tetraplegics in spinal shock. Q J Med (1979) 0.89
Effects of the peptide release inhibitor, octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure. J Hypertens (1995) 0.88
The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine. J Neurol Neurosurg Psychiatry (1989) 0.88